IP Library › Granted Patent US 9,974,437
Granted Patent B2
US 9,974,437 · App. 15/309,392 · Granted May 22, 2018

Device and method to quantify vitreous opacity impairment

Inventor: Edwin Ryan (St. Paul, MN)
Assignee: Edwin Ryan
A61B3/145A61B3/1025A61B3/14A61B3/152G06T7/0016H04N5/33G06T2207/10016G06T2207/10048G06T2207/30041
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,974,437
App. No.
15/309,392
Granted
May 22, 2018
Kind
B2
Abstract

Examples of devices and method for quantifying opacities in ah eye are shown. Examples include analysis of still images or video images. In one example a cross section area of opacities within a visual axis are quantified. Opacities in the vitreous of an eye, such as “floaters” can vary in severity from little or no reduction in vision, to bothersome, to high reduction in visual function. It is desirable to be able to quantify a level of severity of visual obstruction within a patient's eye and proceed with a level of treatment to match the condition.

Claims (40)

1. An ophthalmological diagnostic device, comprising:

a vitreous imager;

an image analysis system configured to detect opacities within a vitreous; and

a retina analysis system configured to quantify an amount of obstruction of the retina from the opacities, wherein the vitreous imager is configured to capture and record video images, and the retina analysis system is configured to quantify an amount of obstruction of the retina per unit of time over a duration of at least a portion of a video.

2. The ophthalmological diagnostic device of claim 1 , wherein the vitreous imager is configured to capture still photo images.

3. The ophthalmological diagnostic device of claim 1 , further including a number of controlled targets to direct a patient's eye in a controlled way during a video image capture.

4. The ophthalmological diagnostic device of claim 1 , wherein the vitreous imager includes an infrared spectrum imager.

5. A method, comprising:

imaging a vitreous of an eye;

detecting opacities within the vitreous;

quantifying a cross section area of the opacities within the vitreous; and

quantifying an amount of the cross section area of the opacities that obstruct a retina, wherein imagine the vitreous of the eye includes video imaging, and quantifying the amount of the cross section area of the opacities that obstruct the retina includes quantifying an amount of obstruction over time in a video.

6. The method of claim 5 , wherein imaging the vitreous of the eye includes infrared imaging.

7. The method of claim 5 , wherein imaging the vitreous of the eye includes still photographic imaging.

8. The method of claim 5 , further including directing a patient to look from one direction to another in a controlled manner during video imaging.

9. An ophthalmological diagnostic device, comprising:

vitreous imager, wherein the vitreous imager is configured to capture and record video images;

an image analysis system configured to detect opacities within a vitreous; and

a projector to project text onto a retina; and

a retina analysis system configured to quantify an amount of obstruction of the retina from the opacities, wherein the retina analysis system is configured to quantify an amount of obstruction of the retina per unit of time over a duration of at least a portion of a video.

10. The ophthalmological diagnostic device of claim 9 , wherein the projector includes a scanning laser projector.

11. The ophthalmological diagnostic device of claim 10 , wherein the projector is integrated with the vitreous imager.

12. The ophthalmological diagnostic device of claim 9 , wherein the projector is configured to move a projection location to different portions of the retina.

13. The ophthalmological diagnostic device of claim 9 , further including a testing system to quantify a patient's reading proficiency of the projected text.

14. The ophthalmological diagnostic device of claim 13 , wherein the testing system uses a number of factors to quantify a patient, the factors chosen from a group consisting of:

an amount of obstruction of the retina from the opacities over time;

a reading speed of the projected text;

an amount of movement of the projected text; and

an amount of movement of the vitreous.

15. An evaluation method, comprising:

imaging a vitreous of an eye;

detecting opacities within the vitreous;

projecting text onto a retina of the eye;

quantifying a reading proficiency of the projected text; and

quantifying any obstruction of the retina from the opacities while the reading proficiency is being quantified, wherein a quantified evaluation score includes a factor of amount of obstruction over time.

16. The evaluation method of claim 15 , wherein projecting text onto a retina of the eye includes moving text to different locations over the retina during the evaluation method.

17. The evaluation method of claim 15 , wherein quantifying a reading proficiency includes quantifying a reading speed.

18. The evaluation method of claim 15 , wherein a quantified evaluation score includes a factor of an amount of vitreous movement.

19. The evaluation method of claim 15 , wherein a quantified evaluation score includes a factor of an amount of projected text movement.

20. The evaluation method of claim 15 , wherein projecting text onto the retina of the eye include scanning text onto a retina of the eye using a laser.

Continuity (3)
Provisional Application 62062617 · Oct 10, 2014
Provisional Application 61989931 · May 7, 2014
Related Publication 20170065173A1 · Mar 9, 2017